Novavax - Intraday - We look to Sell at 110.96 (stop at 127.66) Previous support level of 120.00 broken. Daily signals are bearish. We look for losses to be extended today. The bias is still for lower levels and we look for any gains to be limited. Our profit targets will be 77.28 and 55.00 Resistance: 120.00 / 140.00 / 150.00 Support: 110.00 / 80.00 /...
Novavax daily chart now have Bull divergence pattern after correction. Chart shows possible path to ATH or next support level. NAF DYOR
first of all thanks for stopping by.. This text below will be posted on every timeframe Until now, not much was known about Novavax because it was Moderna or Pfizer what was on the news and media, but now NOVAVAX has been in the news and so that's why the chart popped up on my radar . On the big picture I'm looking at the 2 monthly chart To remove some noise and...
first of all thanks for stopping by.. This text below will be posted on every timeframe Until now, not much was known about Novavax because it was Moderna or Pfizer what was on the news and media, but now NOVAVAX has been in the news and so that's why the chart popped up on my radar . On the big picture I'm looking at the 2 monthly chart To remove some noise and...
first of all thanks for stopping by.. This text below will be posted on every timeframe Until now, not much was known about Novavax because it was Moderna or Pfizer what was on the news and media, but now NOVAVAX has been in the news and so that's why the chart popped up on my radar . On the big picture I'm looking at the 2 monthly chart To remove some noise and...
Similarities can be seen in red,yellow,green The breakabove the fib circle level, which has previously been seen as a strong resistance point is an extremely good sign along with the possible development of a vaccine for a new variant (if the current vaccine isn't effective) NVAX looks bullish
Pfizer's monopoly is very strong on the Covid-19 vaccines . They are spending millions hiding their side effects and creating hurdles for their competitors at the regulatory agencies SUCCESSFULLY . It maybe that Novavax has one the best products out there but that simply does not matter at this point , we know how powerful big pharma can be and Novavax's lateness...
Hi there. Price is forming a continuation pattern to the upside. Watch strong price action at the current levels for buy.
Novavax will issue a statement ahead of their upcoming earnings in a couple of weeks that they have scrapped the plans for a Covid-19 vaccine and now instead they are working on a Covid-flu combo for the next year . The insiders and the main hedge fund manager Peter Kolchinsky have already shorted the stock last week . I fully expect It will be anywhere between...
Novavax is one of the pharmaceutical companies that is delaying the launch of its vaccine, due to regulatory issues, other pharmaceutical companies such as Pfizer, modern, astrazeneca and j & j (janssen) have an advantage. There is a potential to buy shares of this American pharmaceutical company, due to the demand for its vaccine in different countries, the ones...
On 6/15/2021 Cantor Fitzgerald brokerage Boosted the Price Target from Reduce to Overweight $217.00 to $272.00 On 5/18/2021 JPMorgan Chase & Co. brokerage Reiterated Rating from Overweight to Neutral $285.00 to $161.00 On 5/12/2021 B. Riley brokerage Lowered the Price Target from $365.00 to $286.00 On 5/12/2021 HC Wainwright brokerage Lowered the...
Novavax COVID-19 vaccine more than 90% effective in U.S trial according to Reuters. Despite positive news (which we do not trade), we will share with you our current view on Novavax. a) The price is inside a descending Wedge, and due to positive news, we are observing a bullish GAP, and we may see the price outside the Wedge pattern b) The general strategy...
Possible eve and adam double bottom pattern. 630 possible if this stock makes new high.
NVAX could not even break and retest the old Resistance from August, it also formed a nice setup, where the break was also a break of the downtrendline at the same time. Todays Session retested both, now forming a double support, which could allow us some decent gains...
* This is not financial advice. This is my non-expert opinion. * Vistagen ( NASDAQ:VTGN ) is a clinical stage biopharmaceutical company with long-term potential. I believe it's technology is similarly game-changing the way I believe NanoFlu for Novavax is (www.novavax.com) ( ). It could have positive outcomes for the world. I hope that their tech comes to...
RSI same resistance UPTREND trend line Until up trend huge break out!!
Soon huge break out..! I bought again today at 122,80$
if market keep is bullish euphorique structure, we are close to start the 3 wave that is extensive. fundamental: with covid trubbles and vaccination approval we can see that the probable futur trend will be bullish. investor tend to go with hot stocks or easy to guest safe heaven sector, in the case of a global pendemie the one industry that cannot suffer from...